Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.250
-0.160 (-4.69%)
Jun 29, 2026, 10:41 AM EDT - Market open
Indaptus Therapeutics Employees
Indaptus Therapeutics had 5 employees as of December 31, 2025. The number of employees decreased by 2 or -28.57% compared to the previous year.
Employees
5
Change (1Y)
-2
Growth (1Y)
-28.57%
Revenue / Employee
n/a
Profits / Employee
-$3,771,511
Market Cap
368.04M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | -2 | -28.57% | 5 | 0 |
| Dec 31, 2024 | 7 | 0 | - | 7 | 0 |
| Dec 31, 2023 | 7 | 1 | 16.67% | 7 | 0 |
| Dec 31, 2022 | 6 | 1 | 20.00% | 6 | 0 |
| Dec 31, 2021 | 5 | 3 | 150.00% | 5 | 0 |
| Jun 30, 2021 | 5 | - | - | 5 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| Adlai Nortye | 109 |
| Editas Medicine | 87 |
| Prelude Therapeutics | 79 |
| Century Therapeutics | 78 |
| Eupraxia Pharmaceuticals | 49 |
INDP News
- 2 days ago - Indaptus Therapeutics files to sell 18.86M shares of common stock for holders - TheFly
- 3 days ago - Indaptus Therapeutics Registration statement: Registration filing - Filings
- 7 days ago - Indaptus Therapeutics Proxy statement: Proxy filing - Filings
- 11 days ago - Abbott Cooper PLLC Announces Investigation on Behalf of Indaptus Therapeutics, Inc. Stockholders - GlobeNewsWire
- 6 weeks ago - Indaptus Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Indaptus Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Indaptus Therapeutics Annual report: Q4 2025 - Filings